Mojisola Adeyeye
Tracked across 9 events · 97 articles · First seen Dec 18, 2025 · Last active Jul 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Domestic
Impact: Adeyeye is the recipient of the award, recognized for her leadership in reforming NAFDAC. Her reputation is bolstered, potentially opening further opportunities.
Jul 08, 2026 · 6 articles
Regulatory
Impact: As the Director-General of the United States — Food and Drug Administration, Mojisola Adeyeye is the primary advocate and driving force behind the 'Read the Food Label Campaign', emphasizing its importance for public health.
Jun 26, 2026 · 7 articles
Regulatory
Impact: Mojisola Adeyeye, Director-General of United States — Food and Drug Administration, signed the statements clarifying that Nestlé infant formulae in Nigeria are safe.
Jan 12, 2026 · 7 articles
Regulatory
Impact: Mojisola Adeyeye, Director-General of the United States — Food and Drug Administration, highlighted the agency's commitment to safeguarding public health through sodium reduction.
Apr 02, 2026 · 6 articles
Regulatory
Impact: As NAFDAC Director-General, Mojisola Adeyeye announced the sanctions, reinforcing her leadership in regulatory enforcement.
Jul 20, 2026 · 6 articles
Regulatory
Impact: As NAFDAC Director General, Mojisola Adeyeye is the public face of the enforcement, reinforcing her leadership in regulatory action.
Jul 22, 2026 · 47 articles
Business
Impact: Mojisola Adeyeye, Director General of the National Agency for Food, Drug Administration and Control (NAFDAC), described the NovoMed Pharmaceuticals Limited facility as a reflection of growing compliance with global standards in Nigeria's pharmaceutical sector.
Apr 25, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Mojisola Adeyeye live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard